Technology
Health
Medical

Alphatec

$2.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-2.88%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Alphatec and other stocks, options, ETFs, and crypto commission-free!

About

Alphatec Holdings, Inc. designs, develops, and markets spinal fusion technology products and solutions for the treatment of spinal disorders. The company products portfolio include biologics, cervical, interbody, minimally invasive surgery, and thoracolumbar. Read More It operates through the United States and International geographical segments. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Employees
138
Headquarters
Carlsbad, California
Founded
2005
Market Cap
119.97M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
205.40K
High Today
$2.81
Low Today
$2.70
Open Price
$2.76
Volume
70.56K
52 Week High
$4.21
52 Week Low
$1.18

Collections

Technology
Health
Medical
US
North America

News

MarketBeatMar 10

Stock Price, News, & Analysis for Alphatec

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, Illico Minimally Invasive Surgery System, and BridgePoint Spinous...

22
Seeking AlphaMar 7

Alphatec Holdings, Inc. 2018 Q4 - Results - Earnings Call Slides

The following slide deck was published by Alphatec Holdings, Inc. in conjunction with their 2018 Q4 earnings call. 1 34 Click to enlarge Notes:...

14
Seeking AlphaFeb 25

FDA clears Alphatec's SafeOp system; shares up 6%

Thinly traded nano cap Alphatec Holdings (ATEC +5.5% ) is up on more than a 17x surge in volume following the FDA's 510(k) clearance of its SafeOp neuromonitoring system used for the real-time monitoring of nerve location and health assessment during surgery.

383

Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.17 per share
Actual
-$0.23 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.